MOSCOW: President Vladimir Putin said on Tuesday [ 11 August 2020 ] that Russia had become the “world’s first” country to grant regulatory approval to the COVID-19 vaccine after less than two months of human testing, a move hailed by Moscow as evidence of its scientific prowess.
Mr. Putin also stated that one of his daughters had tested a Russian COVID-19 vaccine on herself and that she is feeling well. The Russian leader noted that the first COVID-19 vaccine forms stable cell and antibody immunity. Mr. Putin claims that this vaccine is pretty effective when one of his daughters got vaccinated and in that sense, she took part in the testing. He noted that after the first dose of vaccine his daughter has 38°C and on the next day a slightly higher than 37°C. And after getting the second shot, she had a slight fever again, and then everything was fine, she is feeling well and now has a good Antibody count, the president informed.
The Russian president has two daughters – Maria, born in 1885, and Katerina, born in 1986
According to Health Minister Mikhail Murashko, the vaccine was developed by the Gamaleya National Research Center for Epidemiology and Microbiology. Russian officials said that the vaccine had been named “SPUTNIK-V”, in honor of the world’s first man-made satellite launched by the Soviet Union. In Russian language Sputnik is known as a satellite.
Russia had allowed clinical trials of two forms of a potential Covid-19 vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology on June 18.The first vaccine, in the form of a solution for intramuscular administration, was carried out at the Burdenko Military Hospital.Another vaccine, in the form of a powder for the preparation of a solution for intramuscular administration, was carried out at Sechenov First Moscow State Medical University.
The first stage of research on the vaccine at Sechenov University involved a group of 18 volunteers and the second group involved 20 volunteers. After vaccination, all volunteers were expected to remain in isolation in a hospital for 28 days. Earlier, results of the COVID-19 vaccine tests performed on a group of volunteers in Russia showed that they were developing immunity to the coronavirus.
“The data obtained by the Gamalei National Research Center for Epidemiology and Microbiology proves that volunteers of the first and second groups are forming an immune response after injections of the vaccine against the coronavirus,” according to an earlier statement from the Russian Defense Ministry.
Russia’s Vector State Research Center of Virology and Biotechnology plans to launch production of the novel coronavirus vaccine in November, its Director-General Rinat Maksyutov told Vesti program on Rossiya-1 TV channel.
“We expect to start production already in November this year. So, closer to the end of the year and the start of the next year we can talk about switching to vaccination at least for people from risk groups with a further switch to massive vaccination,” Maksyutov said.
Russia has reported 719,449 cases and 11,188 deaths to date. There are at least 21 vaccines currently under key trials, according to the World Health Organisation (WHO).
The overall number of global COVID-19 cases was nearing 12.7 million, while the deaths have increased to more than 564,000, according to Johns Hopkins University in the US.
The US accounted for the world’s highest number of infections and fatalities at 3,245,158 and 134,764. Brazil came in the second place with 1,839,850 infections and 71,469 deaths.
Russia will manufacture several million doses of coronavirus vaccines per month by the beginning of the next year 2021, Russian Industry and Trade Minister Denis Manturov said in an interview with TASS.